Integrating multi-omics data reveals the antitumor role and clinical benefits of gamma-delta T cells in triple-negative breast cancer
Our study provides novel insight and a theoretical basis for individualized therapy of patients with TNBC based on γδT cells.
Authors
- Yao Tian (ORCID: https://orcid.org/0000-0003-4680-6889)
- Chenglu Lu (ORCID: https://orcid.org/0000-0002-5198-0016)
- Guixin Wang (ORCID: https://orcid.org/0000-0002-4850-9207)
- Yingxi Li (ORCID: https://orcid.org/0000-0002-3848-1992)
- Xuejun Wang (ORCID: https://orcid.org/0000-0001-9267-1343)
- Xiaoning Wang (ORCID: https://orcid.org/0000-0002-7925-2774)
- Yue Yu (ORCID: https://orcid.org/0000-0003-2053-9866)
- Shuo Wang (ORCID: https://orcid.org/0000-0002-7443-7999)
- Zhaohui Chen (ORCID: https://orcid.org/0000-0003-0688-9798)
- Zhaoyi Liu (ORCID: https://orcid.org/0000-0001-8563-7665)
- Long He (ORCID: https://orcid.org/0000-0002-2814-6541)
- Yizeng Wang
- Wenbin Song
- Cangchang Shi
Institutions
- Tianjin Medical University General Hospital (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Tangshan People's Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1186/s12885-025-14029-8
- Citations
- 9
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 9.41
Funders
- National Natural Science Foundation of China